Cite
HARVARD Citation
Wyles, D. et al. (2018). Glecaprevir/pibrentasvir for hepatitis C virus genotype 3 patients with cirrhosis and/or prior treatment experience: A partially randomized phase 3 clinical trial. Hepatology. 67 (2), pp. 514-523. [Online].